Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
Melanoma is the deadliest form of skin cancer and has an incidence that is rising faster than any other solid tumor. Metastatic melanoma treatment has considerably progressed in the past five years with the introduction of targeted therapy (BRAF and MEK inhibitors) and immune checkpoint blockade (an...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Chinese Anti-Cancer Association
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296084/ |